BioCentury
ARTICLE | Clinical News

TRO40303: Phase I data

March 7, 2011 8:00 AM UTC

A placebo-controlled Phase I trial in 72 healthy volunteers showed that single escalating-doses of IV TRO40303 were safe. Trophos plans to start a Phase II trial of TRO40303 to treat acute myocardial ...